• Home
  • Huntington’s disease
  • important
  • Articles
    • Scientific Articles Free
    • Italian articles
  • ARTICLES SCIENTIFIC
  • Link
Search
  • Contact
  • Sitemap
  • Donate
  • Newsletters
  • www.aichroma.com
  • Italian | Español | French

Huntington's Disease News

  • Home
  • Huntington’s disease
  • important
    • uniQure Announces Publications of Preclinical Data for AMT-130 in Huntington’s Disease…

      uniQure Announces Completion of Enrollment in First Cohort of Phase I/II…

      Roche provides update on tominersen programme in manifest Huntington’s disease

      uniQure Announces Positive Recommendation from Data Safety Monitoring Board of Phase…

      Discovery shows promise for treating Huntington’s Disease

  • Articles
    • Scientific Articles Free
    • Italian articles
  • ARTICLES SCIENTIFIC
  • Link

Optogenetic stimulation improves alterations in movement and behaviour of experimental models...

Nov 11, 2020

Two-birds-one-stone strategy shows promise in RNA-repeat expansion diseases

Nov 9, 2020

Huntington Study Group (HSG) 2020 Annual Conference: HD in Focus –...

Nov 2, 2020

Huntington Study Group (HSG) 2020 Annual Conference: HD in Focus –...

Nov 2, 2020

CORRECTION — Vaccinex to Present Additional SIGNAL Data at Huntington Study...

Ott 29, 2020

Prilenia Enrolls First Patients Into its PROOF-HD Phase 3 Clinical Trial...

Ott 27, 2020

Treatment for neurological disorder could be repurposed for Huntington’s disease patients

Ott 23, 2020

Novartis receives US Food and Drug Administration (FDA) Orphan Drug Designation...

Ott 21, 2020

uniQure Announces Enrollment of Next Two Patients in Phase I/II Clinical...

Ott 14, 2020

Updates from the EHDN Plenary Meeting 2020

Ott 7, 2020
1234...129Page 3 of 129
ABOUT US
AICH - ROMA ONLUS: VIA NOMENTANA 56, 00161 ROMA TEL/FAX 06.44242033 c/c postale n. 35453000 C.F. 96152570584
FOLLOW US
  • Discliminair
  • Contact
  • Donate
  • Sitemap
© newshd.net
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.Accept Discliminair
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Sempre abilitato

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.

ACCETTA E SALVA